Shaping the Future of Global Next-Generation Influenza Vaccine Research
Flu Vaccine Forum. A series of conversations with global public health experts about transforming the vaccine ecosystem towards a flu-free future.
Rate of Hospitalizations and Mortality of Respiratory Syncytial Virus Infection Compared to Influenza in Older People: A Systematic Review and Meta-Analysis
Since the data regarding the impact of RSV are still limited for older people, the aim of this systematic review and meta-analysis is to compare the rate of hospitalization and mortality between RSV and influenza in this population.
Patients believe that the accessibility of GP care is under pressure due to COVID-19 measures
The COVID-19 pandemic has enormous impact on healthcare systems worldwide.
"Protection against influenza and its complications in the context of Covid-19” symposium at Options XI
The Covid-19 pandemic has affected influenza circulation globally, surveillance is important to assess the upcoming season. Influenza is back!
News
Policy & Recommendations
Health Brief by EurActiv: Lessons on inequality from COVID-19
As the EU’s COVI committee continues its discussions on lessons to be learnt from the COVID-19 pandemic, lawmakers are investigating how the past two years have impacted the most economically vulnerable in Europe.
News
Policy & Recommendations
EU Global Health Strategy to improve global health security and deliver better health for all
On 30 November, The European Commission adopted Europe’s agenda for global health action for the next 10 years.
Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities
Biotherapeutics, such as recombinant proteins and monoclonal antibodies, have become mainstays of modern medicine as shown by their increasing number in the WHO Model List of Essential Medicines.
Why Are Lots of Kids Likely to Be Sick This Holiday Season?
Opinion by Florian Krammer and Aubree Gordon
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
Seasonal influenza vaccines offer little protection against pandemic influenza virus strains.
Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons
We observed the interference between two prevalent respiratory viruses, respiratory syncytial virus (RSV) and influenza A virus (IAV) (H1N1), and characterized its molecular underpinnings in alveolar epithelial cells (A549).
|
9th Influenza Conference 2023
#ESWI2023: Call for abstracts now open
The deadline for abstract submissions is 14 May 2023 23:59 CET.
